Avantra Family Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$768K Sell
835
-172
-17% -$174K 0.57% 54
2025
Q4
$1.08M Sell
1,007
-16
-2% -$15.3K 0.79% 39
2025
Q3
$781K Buy
1,023
+1
+0.1% +$744 0.58% 49
2025
Q2
$797K Sell
1,022
-241
-19% -$187K 0.66% 42
2025
Q1
$1.04M Sell
1,263
-17
-1% -$14.1K 1% 25
2024
Q4
$988K Buy
+1,280
New +$1.06M 0.92% 27

Other funds holding LLY

Avantra Family Wealth's LLY Position: Q1 2026 in Review

Avantra Family Wealth reduced its Eli Lilly (LLY) stake by 17% in Q1 2026, selling an estimated $174K and leaving 835 shares worth $768K. The position accounts for 0.57% of the portfolio, ranked #54.

Avantra Family Wealth first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.08M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Avantra Family Wealth held 835 shares of Eli Lilly worth $768K as of Q1 2026.
  • Avantra Family Wealth sold 172 Eli Lilly shares in Q1 2026, an estimated $174K.
  • Eli Lilly made up 0.57% of Avantra Family Wealth's portfolio in Q1 2026, its #54 holding.
  • Avantra Family Wealth first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Avantra Family Wealth's Eli Lilly position peaked at $1.08M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Avantra Family Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.